Published by Coherent Market Insights
Posted on October 4, 2021
5 min readLast updated: January 31, 2026
The Radiofrequency Ablation Devices Market is set for growth from 2021 to 2028, driven by cancer treatment needs and technological advancements.
Radiofrequency Ablation Devices Market is expanding rapidly with Abbott Laboratories introducing IconicRF Generator for minimally invasive treatment pain in the nervous system
Radiofrequency Ablation is a minimally intrusive cosmetic surgical treatment, which involves a lightweight, local anesthetic and minimal sedation. This treatment is typically used to treat chronic low back and neck pain. The treatment involves heating up a small portion of nerves under controlled medical and controlled pressure and this help to block pain signals sending from that same area to another area.
Request For Sample Copy of This Premium Research Radiofrequency Ablation Devices Market @
https://www.coherentmarketinsights.com/insight/request-sample/4252
Growing incidence of cancer is one of the primary factors fueling growth of the said market. Ablation devices are used in minimally invasive procedures where they use electrical energy and heat to destroy cancer cells. As per the World Health Organization (WHO), in 2018, around 9.6 million deaths were reported due to cancer globally, of which 2.09 million cases were due to lung cancer. As per the same source, in 2018, around 9.6 million deaths were reported due to cancer globally, of which 2.09 million cases were due to lung cancer. Hence, such factors can stimulate growth of the radiofrequency ablation devices market.
Apart from cancer prevalence, the emergence of advanced next-generation ablation is proving to be critical in the development of the market. Key players operating in the medical devices sector are focused on research and development activities, in order to come up with advanced ablation products and technologies. Thus, such factors can augment growth of the radiofrequency ablation devices market. Recently, in November 2020, Abbott Laboratories launched IconicRF Generator for minimally invasive treatment of the management of pain in the nervous system.
When it comes to regional impact, North America seems to be gaining significant traction in the radiofrequency ablation devices market. This is due to high purchasing power and technological advancements in medical devices in the region. On the contrary, Asia Pacific is exhibiting a positive outlook due to improving healthcare infrastructure rising disposable income in the region.
Radiofrequency ablation devices have been used successfully for treating discomfort and pain in the lumbar region, hips, knees, shoulders, and neck. Furthermore, it has also been shown to provide relief from problems associated with osteoarthritis, which affects the knees, hips, and spinal cord. Regardless of these factors, certain challenges remain prevalent in the market. For instance, high costs associated with ablation devices can restrict the potential market growth. Furthermore, unfavorable regulatory scenarios and frequent product recalls can impede growth of the radiofrequency ablation devices market in the near future.
Major Players in Radiofrequency Ablation Devices Market
Accuray, Inc., Avanos Medical, Inc., Boston Scientific Corporation, Biosense Webster, Inc., Cosman Medical, Inc., Diros Technology, Inc., Kimberly-Clark Corporation, NeuroTherm, Inc., St. Jude Medical, Inc., and Stryker Corporation.
Ask for PDF sample copy of the Radiofrequency Ablation Devices market report @
https://www.coherentmarketinsights.com/insight/request-pdf/4252
Radiofrequency Ablation Devices Market insights will improve the revenue impact of businesses in various industries:
• providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Radiofrequency Ablation Devices Market
• Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Radiofrequency Ablation Devices market and offers solutions
• assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
• provides an understanding of disruptive technology trends to help businesses make their transitions smoothly
• helping leading companies make strategy recalibrations ahead of their competitors and peers
• Offers insights into promising growth for top players aiming to retain their leadership position in the market & supply-side analysis of the Radiofrequency Ablation Devices market.
Reasons to Purchase this Report
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4252
In conclusion, the Radiofrequency Ablation Devices market report presents the descriptive analysis of the parent market supported elite players, present, past, and artistic movement information which is in a position to function as a profitable guide for all the Radiofrequency Ablation Devices industry business competitors. Our expert research analyst’s team has been trained to supply in-depth marketing research reports from every individual sector which can be helpful to know the industry data within the most precise way.
Contact:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Radiofrequency Ablation Devices Market to See Booming Growth 2021-2028 | Accuray, Inc., Avanos Medical, Inc., Boston Scientific Corporation, Biosense Webster, Inc appeared first on Gatorledger.
The article focuses on the growth of the Radiofrequency Ablation Devices Market from 2021 to 2028.
The market is driven by the prevalence of cancer and advancements in minimally invasive treatments.
North America and Asia Pacific are significant regions due to technological advancements and improving healthcare infrastructure.
Explore more articles in the Research Reports category
